Cambridge Investment Research Advisors
INSP icon

Cambridge Investment Research Advisors’s Inspire Medical Systems INSP Stock Holding History

Cambridge Investment Research Advisors’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387K Buy
+8,674
New +$411K ﹤0.01% 3205
2026
Q1 		– Sell
-12,592
Closed -$1.16M – 4003
2025
Q4 		$1.16M Buy
+12,592
New +$1.2M ﹤0.01% 1984
2023
Q3 		– Sell
-1,093
Closed -$355K – 3206
2023
Q2 		$355K Sell
1,093
-226
-17% -$64.6K ﹤0.01% 2405
2023
Q1 		$309K Sell
1,319
-930
-41% -$235K ﹤0.01% 2463
2022
Q4 		$566K Buy
2,249
+820
+57% +$175K ﹤0.01% 1918
2022
Q3 		$253K Buy
1,429
+311
+28% +$62.5K ﹤0.01% 2506
2022
Q2 		$204K Buy
1,118
+74
+7% +$14.8K ﹤0.01% 2709
2022
Q1 		$268K Sell
1,044
-301
-22% -$68.8K ﹤0.01% 2644
2021
Q4 		$309K Buy
+1,345
New +$328K ﹤0.01% 2502

Other funds holding INSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cambridge Investment Research Advisors's INSP Position: Q2 2026 in Review

Cambridge Investment Research Advisors opened a new position in Inspire Medical Systems (INSP) in Q2 2026: 8,674 shares worth $387K. The stake represents ﹤0.01% of the portfolio and ranks #3205 among its holdings. This is a return to the name: Cambridge Investment Research Advisors previously reported a position in INSP as recently as Q4 2025.

Cambridge Investment Research Advisors first reported a position in INSP in Q4 2021 and has held it in 9 quarters since. The position peaked at $1.16M in Q4 2025. 275 funds tracked by Wall St. Rank hold INSP as of Q2 2026.

  • Cambridge Investment Research Advisors held 8,674 shares of Inspire Medical Systems worth $387K as of Q2 2026.
  • Inspire Medical Systems was a new Cambridge Investment Research Advisors position in Q2 2026.
  • Inspire Medical Systems made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3205 holding.
  • Cambridge Investment Research Advisors first reported a position in Inspire Medical Systems in Q4 2021 and has held it in 9 quarters since.
  • Cambridge Investment Research Advisors's Inspire Medical Systems position peaked at $1.16M in Q4 2025.
  • 275 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.